Dare Bioscience (DARE) Enterprise Value (2016 - 2025)
Dare Bioscience (DARE) has disclosed Enterprise Value for 11 consecutive years, with -$23.1 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value fell 105.43% year-over-year to -$23.1 million, compared with a TTM value of -$23.1 million through Sep 2025, down 105.43%, and an annual FY2024 reading of -$15.7 million, down 49.85% over the prior year.
- Enterprise Value was -$23.1 million for Q3 2025 at Dare Bioscience, down from -$5.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$3.6 million in Q1 2024 and bottomed at -$51.7 million in Q4 2021.
- Average Enterprise Value over 5 years is -$21.2 million, with a median of -$15.7 million recorded in 2024.
- The sharpest move saw Enterprise Value tumbled 1006.64% in 2021, then soared 81.61% in 2024.
- Year by year, Enterprise Value stood at -$51.7 million in 2021, then surged by 32.91% to -$34.7 million in 2022, then soared by 69.78% to -$10.5 million in 2023, then tumbled by 49.85% to -$15.7 million in 2024, then tumbled by 46.99% to -$23.1 million in 2025.
- Business Quant data shows Enterprise Value for DARE at -$23.1 million in Q3 2025, -$5.0 million in Q2 2025, and -$10.3 million in Q1 2025.